Skip to main content
. 2022 Jul 27;13:970117. doi: 10.3389/fimmu.2022.970117

Figure 11.

Figure 11

The development of promising therapeutic agents and description of targeted molecules and corresponding pathways. (A–E) The promising therapeutic agents for patients in C2, including ABT.263 (A), ATRA (B), BIBW2992 (C), JNK.Inhibitor.VIII (D), and PF.4708671 (E). (F) Heatmap of enrichment score generated from potential therapeutic compounds. (G) The description of the mode of action (MoA) of compounds targeting corresponding molecular pathways. ***p < 0.001.